ArticleFrontiers in microbiology2017
Evolution of Anabaenopeptin Peptide Structural Variability in the Cyanobacterium
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 37 citations in OpenAlex.
- Evolutionary strategies of late-stage diversification in bacterial biosynthetic gene clusters.Essays in biochemistry · 2026Review
- Subcellular visualization and quantification of cyanotoxin synthesis in cyanobacteria reveals distinct compartmentation.Scientific reports · 2026Article
- Structure-Activity Relationships of Anabaenopeptins as Carboxypeptidase and Phosphatase Inhibitors.ACS chemical biology · 2026Review
- Secondary metabolism ofApplied and environmental microbiology · 2026Review
- Alteration in Amino Acid Composition and Configuration in Cyanobacterial Peptides Affects Biological Activity.Journal of natural products · 2025Article
- Article
- Article
- Lake Avernus Has Turned Red: Bioindicator Monitoring Unveils the Secrets of "Gates of Hades".Toxins · 2023Article
- High Structural Diversity of Aeruginosins in Bloom-Forming Cyanobacteria of the GenusMarine drugs · 2023Article
- Hydantoanabaenopeptins from Lake KinneretMarine drugs · 2023Article
- Article
- Review
- Anabaenopeptins fromInternational journal of environmental research and public health · 2022Article
- Insights into the Antimicrobial Activities and Metabolomes ofMarine drugs · 2022Article
- Biocontrol properties from phyllospheric bacteria isolated from Solanum lycopersicum and Lactuca sativa and genome mining of antimicrobial gene clusters.BMC genomics · 2022Article
- Article
- Toxic/Bioactive Peptide Synthesis Genes Rearranged by Insertion Sequence Elements Among the Bloom-Forming CyanobacteriaFrontiers in microbiology · 2022Article
- Article
- Anabaenopeptins: What We Know So Far.Toxins · 2021Review
- Differential Labeling of Chemically Modified Peptides and Lipids among CyanobacteriaMicroorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
Cyanobacteria are frequently involved in the formation of harmful algal blooms wherein, apart from the toxic microcystins, other groups of bioactive peptides are abundant as well, such as anabaenopeptins (APs). The APs are synthesized nonribosomally as cyclic hexapeptides with various amino acids at the exocyclic position. We investigated the presence and recombination of the AP synthesis gene cluster (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.